PD09.02. Nutritional Vulnerability Predicts Treatment Delivery and Survival in Locally Advanced Esophageal Squamous Cell Carcinoma Undergoing Neoadjuvant Immunochemotherapy

Clicks: 19
ID: 326132
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #230 of 453 articles by views in diseases of the esophagus : official journal of the international society for diseases of the esophagus

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 453 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Abstract Topic Esophageal Cancer: Other Background Malnutrition is highly prevalent in esophageal squamous cell carcinoma (ESCC) and may critically modulate host resilience to intensive multimodal therapy. In the era of neoadjuvant immunochemotherapy (nICT), the prognostic utility of structured nutritional assessment remains incompletely defined. This study aimed to establish clinically relevant Patient-Generated Subjective Global Assessment (PG-SGA) thresholds and to determine their associations with treatment feasibility and oncologic outcomes. Methods This multicenter retrospective cohort included 498 patients with potentially resectable locally advanced ESCC treated with 2–4 cycles of platinum–taxane chemotherapy combined with a programmed cell death-1 inhibitor, followed by planned esophagectomy. Optimal PG-SGA cut points were derived using classification and regression tree analysis to stratify nutritional risk. Associations between nutritional strata and neoadjuvant treatment completion, severe toxicities, postoperative morbidity, overall survival (OS), and disease-free survival (DFS) were evaluated. Multivariable Cox regression models adjusted for clinicopathologic characteristics and pathological response. Results PG-SGA scores were categorized into low (≤10; n = 309), intermediate (11–12; n = 90), and high (>12; n = 99) nutritional risk groups. A graded decline in surgical completion was observed across strata (97.1%, 93.3%, and 76.7%, respectively; P < 0.001), accompanied by a stepwise increase in grade ≥3 treatment-related toxicities (21.0%, 36.7%, and 51.5%; P < 0.001). Rates of postoperative pneumonia and intensive care unit utilization similarly rose with worsening nutritional status. Survival outcomes demonstrated a clear gradient: 2-/3-year OS rates were 82.7%/76.4% in the low-risk group, 75.6%/66.7% in the intermediate-risk group, and 59.5%/43.2% in the high-risk group (P < 0.001). Among patients who underwent resection, inferior survival persisted in the high-risk category. After multivariable adjustment, PG-SGA >12 independently predicted poorer OS (hazard ratio 2.03) and DFS (hazard ratio 1.75). Notably, in patients with high nutritional risk, receipt of postoperative immunotherapy was associated with significant improvement in 2-/3-year OS. Conclusion A PG-SGA score >12 delineates a nutritionally vulnerable ESCC subgroup characterized by compromised treatment completion, heightened perioperative morbidity, and inferior survival following nICT. Incorporating standardized nutritional risk stratification into routine care may facilitate early supportive interventions and inform individualized postoperative therapeutic decision-making.
Reference Key
openalex_W7203993764 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors
Journal diseases of the esophagus : official journal of the international society for diseases of the esophagus
Year 2026
DOI
10.1093/dote/doag077.141
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.